Hundreds of people have reported issues with their pancreas, believed to be linked to weight loss and diabetes injections, leading health officials to initiate a new study into potential side effects.

GLP-1 users are posting about side effects and symptoms not seen in clinical trials, including irregular periods, fatigue, ...

GLP-1 users have a reduced appetite, making what they eat more important than ever, experts say. But a new study finds ...

Week Study Evaluates One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obese Otherwise Healthy Adults CAMBRIDGE, Mass., April 10, 2026 /PRNewswire/ ...

As the number of people using these medications has soared, so have anecdotal reports about how they’re impacting users’ ...

Semaglutide 25 mg tablets were tied to significantly greater mean weight loss vs. orforglipron 36 mg tablets, according to ...

The researchers analyzed around 400,000 Reddit posts to find out what patients were saying about the weight loss medications ...

Distinct GLP1R and GIPR variants correlated with nausea/vomiting risk, with a GIPR signal appearing tirzepatide-specific and showing markedly increased vomiting odds. New studies from 23andMe suggest ...

Researchers studied data from 27,885 patients taking GLP1 weight loss drugs such as semaglutide and tirzepatide.

In a recent breakthrough study, the researchers identified previously hidden and unreported side effects stemming from GLP-1 weight loss and diabetes drugs like semaglutide and tirzepatide.

SLIMMERS were today warned that weight loss jabs could trigger two new side effects not listed by manufacturers. Once aimed ...

Researchers analysed more than 400,000 social media posts in a bid to identify lesser-known issues linked to widely used GLP-1 medications semaglutide and tirzepatide.